SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is trending downward following a significant post-earnings sell-off driven by weak future sales guidance and concerns over the company's turnaround progress in key international markets. The investor community remains sharply divided, with some actively buying the dip as a long-term value play, while others criticize the brand's loss of cultural relevance and competitive positioning against emerging sportswear rivals.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to the company's fiscal Q3 earnings report, which highlighted record revenue and international growth, though community sentiment remains polarized over management and the stock's long-term performance. While some participants are betting on an upside reversal tied to broader cannabis sector catalysts and rescheduling prospects, others remain skeptical, citing concerns over dilution and historical share price declines.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors weigh recent capital allocation moves, including a multi-billion dollar stake repurchase in its Irish manufacturing site, against broader market volatility and geopolitical concerns affecting the semiconductor sector. While the community remains divided between long-term bulls highlighting foundry expansion and AI growth and short-term bears skeptical of manufacturing headwinds, active discussion is dominated by the stock's pronounced intraday volatility and its sensitivity to macroeconomic headlines.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating significant buzz as investors track positive Phase 3 clinical data for its lead skin disease treatment, sonelokimab, while speculating on the potential for a high-premium buyout. The community remains deeply divided, with some retail investors holding for generational wealth based on clinical performance while others warn of price manipulation, short-selling pressure, and the impact of institutional divestments.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors focus on the commercial launch of YARTEMLEA, with the community closely tracking initial patient uptake, formulary approvals at major transplant centers, and the company's timeline for reaching positive cash flow. While the stock has faced downward pressure due to technical factors and broader market volatility, discussions are heavily centered on upcoming Q1 sales updates, the potential for milestone payments from the Novo Nordisk partnership, and imminent EU regulatory milestones.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is currently experiencing intense volatility following a significant earnings miss and lowered guidance, with the stock drawing heavy attention due to its massive short interest and the ongoing debate over whether it is a value play or a potential bankruptcy candidate. The community is sharply divided, with bulls betting on a short squeeze and long-term luxury market recovery, while bears point to persistent housing market headwinds, tariff-related margin compression, and expensive international expansion as signs of long-term deterioration.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is experiencing heightened investor interest following the announcement of a massive multi-year AI cloud infrastructure agreement, which has sparked intense debate over the stock's potential for a significant short squeeze. Community members are actively discussing the company's low float and the strategic impact of this contract, leading to speculation about aggressive price moves while some remain cautious of potential spoofing and market volatility.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor ongoing project developments, including the upcoming pilot plant operations and the status of the Definitive Feasibility Study. Market participants are actively debating the stock's valuation relative to its rare earth assets while navigating volatility driven by broader sector trends and geopolitical developments.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors gear up for the upcoming 10-K filing and earnings report, with community members closely tracking the company's aggressive debt reduction efforts and the performance of key holdings like Applied Digital and BW. Bullish participants are actively discussing a potential valuation re-rating and the possibility of a short squeeze, while keeping a watchful eye on management's next steps to address previous legal overhangs and restore institutional confidence.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing significant speculative activity as traders draw comparisons to its past parabolic runs, fueled by a combination of tight float, high short interest, and persistent community speculation regarding a potential meme-style short squeeze. While bulls are actively targeting rapid gains and waiting for volume-driven breakouts, a vocal segment of the community remains skeptical, frequently highlighting the company's lack of revenue and warning others about the risks of being left as exit liquidity in a pump-and-dump setup.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Chain Bridge Bancorp (NYSE:CBNA) Upgraded at Zacks Research

Zacks Research upgraded Chain Bridge Bancorp from a "hold" rating to a "strong-buy" rating in a report on Monday...

Chain Bridge Bancorp, Inc. (CBNA) Upgraded to Strong Buy: Here's What You Should Know

Chain Bridge Bancorp, Inc. (CBNA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Piper Sandler Initiates Coverage on Chain Bridge Bancorp (NYSE:CBNA)

Piper Sandler began coverage on Chain Bridge Bancorp in a research report on Monday. They set a "neutral" rating and a $39.00 target price on the stock...

Cannell Capital LLC Increases Holdings in Chain Bridge Bancorp, Inc. $CBNA

Cannell Capital LLC increased its position in shares of Chain Bridge Bancorp, Inc. (NYSE:CBNA - Free Report) by 239.5% during the 3rd quarter, according to the company in its most recent 13F filing...

Chain Bridge Bancorp, Inc. (NYSE:CBNA) Sees Large Increase in Short Interest

Chain Bridge Bancorp, Inc. (NYSE:CBNA - Get Free Report) saw a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 32,988 shares, a...

Chain Bridge Bancorp (NYSE:CBNA) Director Buys $14,016.00 in Stock

Chain Bridge Bancorp, Inc. (NYSE:CBNA - Get Free Report) Director Leigh-Alexandra Basha acquired 400 shares of the firm's stock in a transaction dated Friday, March 6th. The stock was bought at an...

Insider Buying: Chain Bridge Bancorp (NYSE:CBNA) Director Buys 400 Shares of Stock

Chain Bridge Bancorp, Inc. (NYSE:CBNA - Get Free Report) Director Leigh-Alexandra Basha acquired 400 shares of the stock in a transaction dated Sunday, June 29th. The shares were acquired at an...

Chain Bridge Bancorp (NYSE:CBNA) Director Acquires $12,192.00 in Stock

Chain Bridge Bancorp, Inc. (NYSE:CBNA - Get Free Report) Director Leigh-Alexandra Basha bought 400 shares of the business's stock in a transaction dated Tuesday, November 18th. The stock was acquired...

Chain Bridge Bancorp (NYSE:CBNA) Director Leigh-Alexandra Basha Purchases 400 Shares

Chain Bridge Bancorp, Inc. (NYSE:CBNA - Get Free Report) Director Leigh-Alexandra Basha acquired 400 shares of the stock in a transaction on Sunday, June 29th. The shares were acquired at an average...

Chain Bridge Bancorp (NYSE:CBNA) Insider Purchases $25,168.50 in Stock

Chain Bridge Bancorp, Inc. (NYSE:CBNA - Get Free Report) insider James Pollock acquired 714 shares of the firm's stock in a transaction dated Thursday, March 5th. The shares were purchased at an...

Chain Bridge Bancorp, Inc. is a holding company, which engages in the provision of banking services through its subsidiary. Its services include commercial and personal banking such as deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody. The company was founded by Peter G. Fitzgerald on May 26, 2006 and is headquartered in McLean, VA.

Chain Bridge Bancorp Inc. - Ordinary Shares - Class A

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Current Price	$34.90
Prev Close	$35.65
Open	$35.88
Dividend Yield	0.00%
50-Day Moving Average	$35.25
Beta	0.66
Avg. Volume	5,261.37
PE Ratio	11.32

52-Week High	$38.43
52-Week Low	$20.01
Market Capitalization	$229.9M
EPS (Annual)	$3.08
Price to Book	1.35
Revenue Per Employee	$644,630.44

CBNA
Chain Bridge Bancorp Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CBNA News

CBNAChain Bridge Bancorp Inc. - Ordinary Shares - Class A